Ongoing challenges in the management of malaria

Malaria Journal

Volumn 8, Issue SUPPL. 1, 2009, Pages

  Kokwaro, Gilbert ^a  

^a Consortium for National Health Research ^*  (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; BENFLUMETOL; CHLOROQUINE; FANSIDAR; INSECTICIDE; MEFLOQUINE; PIPERAQUINE; QUININE;

AFRICA; ARTICLE; BED NET; DRUG ELIMINATION; DRUG HALF LIFE; ECONOMIC ASPECT; GAMETOCYTE; MALARIA; MALARIA CONTROL; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; RWANDA; TANZANIA; VECTOR CONTROL; ZAMBIA; ANIMAL; DISEASE CARRIER; DISEASE TRANSMISSION; ECONOMICS; HUMAN; METHODOLOGY; MOSQUITO; PARASITOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIMALARIALS; HUMANS; INSECT VECTORS; MALARIA; MOSQUITO CONTROL; PLASMODIUM FALCIPARUM;

EID: 70350007932     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-S1-S2     Document Type: Article

References (33)

1. WHO World Malaria Report 2008. http://www.who.int/malaria/wmr2008
2. African Malaria Day Fact Sheet (WHO). http://www.rollbackmalaria.org/ docs/AMD/factsheet.htm
3. Roll Back Malaria. Key malaria facts. http://www.rollbackmalaria. org/keyfacts.html
4. Roll Back Malaria Partnership. Africa Malaria Report - 2003. Chapter 2: Insecticide-treated nets. http://rbm.who.int/amd2003/amr2003/pdf/ch2.pdf
5. Roll Back Malaria Partnership. Africa Malaria Report - 2003. Chapter 6: Resource mobilization and financing. http://rbm.who.int/amd2003/amr2003/pdf/ch6. pdf
6. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: Case studies of Zambia, South Africa and Ethiopia. K Barnes P Chanda GA Barnabas, Malar J 2009 8 Suppl 1 8
7. Suppression of exposure to malaria vectors by an order of magnitude using microbial larvicides in rural Kenya. U Fillinger SW Lindsay, Trop Med Int Health 2006 11 1629 1642 10.1111/j.1365-3156.2006.01733.x 17054742
8. Malaria vector control: current and future strategies. W Takken BG Knols, Trends Parasitol 2009 25 101 104 10.1016/j.pt.2008.12.002 19168392
9. WHO Guidelines for the Treatment of Malaria 2006. http://www.who.int/ malaria/docs/TreatmentGuidelines2006.pdf
10. Responding to the challenge of antimalarial drug resistance by routine monitoring to update national malaria treatment policies. LS Vestergaard PL Ringwald, Am J Trop Med Hyg 2007 77 153 159 18165488
11. The use of antimalarials. http://www.rollbackmalaria.org/cmc-upload/0/ 000/014/923/am-1.htm
12. Epidemiology of drug-resistant malaria. C Wongsrichanalai AL Pickard WH Wernsdorfer SR Meshnick, Lancet Infect Dis 2002 2 209 218 10.1016/S1473-3099(02) 00239-6 11937421
13. Antimalarial drug quality in the most severely malarious parts of Africa - a six country study. R Bate P Coticelli R Tren A Attaran, PLoS ONE 2008 3 2132 18461128 10.1371/journal.pone.0002132 (Pubitemid 352025174)
14. Antimalarial drug resistance. NJ White, J Clin Invest 2004 113 1084 1092 15085184
15. The evolution of drug-resistant malaria: the role of drug elimination half-life. IM Hastings WM Watkins NJ White, Philos Trans R Soc Lond B Biol Sci 2002 357 505 519 12028788 10.1098/rstb.2001.1036 (Pubitemid 34489862)
16. Intermittent presumptive treatment for malaria. NJ White, PLoS Med 2005 2 3 15696210 10.1371/journal.pmed.0020003 (Pubitemid 40412728)
17. How antimalarial drug resistance affects post-treatment prophylaxis. NJ White, Malar J 2008 7 9 18186948 10.1186/1475-2875-7-9 (Pubitemid 351327196)
18. A trial of combination antimalarial therapies in children from Papua New Guinea. HA Karunajeewa I Mueller M Senn E Lin I Law PS Gomorrai O Oa S Griffin K Kotab P Suano N Tarongka A Ura D Lautu M Page-Sharp R Wong S Salman P Siba KF Ilett TM Davis, N Engl J Med 2008 359 2545 2557 10.1056/NEJMoa0804915 19064624
19. Clinical pharmacokinetics and pharmacodynamics of artemether- lumefantrine. NJ White M van Vugt F Ezzet, Clin Pharmacokinet 1999 37 105 125 10.2165/00003088-199937020-00002 10496300
20. A clinical and pharmacokinetic trial of six doses of artemether- lumefantrine for mul-tidrug-resistant Plasmodium falciparum malaria in Thailand. G Lefèvre S Looareesuwan S Treeprasertsuk S Krudsood U Silachamroon I Gathmann R Mull R Bakshi, Am J Trop Med Hyg 2001 64 247 256 11463111
21. Deployment of Artemether Lumefantrine (AL) at community level and its impact on malaria specific death rate during an epidemic year [abstract]. A Getachew A Desta H Lemma E Fottrell Tigray Malaria Study Group, Am J Trop Med Hyg 2007 77 206
22. Effects of artemisinin derivatives on malaria transmissibility. RN Price F Nosten C Luxemburger FO ter Kuile L Paiphun T Chongsuphajaisiddhi NJ White, Lancet 1996 347 1654 1658 10.1016/S0140-6736(96)91488-9 8642959
23. A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. L von Seidlein K Bojang P Jones S Jaffar M Pinder S Obaro T Doherty M Haywood G Snounou B Gemperli I Gathmann C Royce K McAdam B Greenwood, Am J Trop Med Hyg 1998 58 638 644 9598454
24. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. CJ Sutherland R Ord S Dunyo M Jawara CJ Drakeley N Alexander R Coleman M Pinder G Walraven GA Targett, PLoS Med 2005 4 92 10.1371/journal.pmed.0020092 (Pubitemid 40721079)
25. Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment. M Otten M Aregawi W Were C Karema A Medin W Bekele D Jima K Gausi R Komatsu E Korenromp D Low-Beer M Grabowsky, Malar J 2009 8 14 19144183 10.1186/1475-2875-8-14
26. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. A Bhattarai AS Ali SP Kachur A Mårtensson AK Abbas R Khatib AW Al-Mafazy M Ramsan G Rotllant JF Gerstenmaier F Molteni S Abdulla SM Montgomery A Kaneko A Björkman, PLoS Med 2007 4 309 17988171 10.1371/journal.pmed.0040309 (Pubitemid 350220531)
27. Community reactions to the introduction of permethrin-treated bed nets for malaria control during a randomized controlled trial in western Kenya. JA Alaii HW Borne SP van den Kachur K Shelley H Mwenesi JM Vulule WA Hawley BL Nahlen PA Phillips-Howard, Am J Trop Med Hyg 2003 68 128 136 12749496 (Pubitemid 38240692)
28. Factors affecting use of permethrin-treated bed nets during a randomized controlled trial in western Kenya. JA Alaii WA Hawley MS Kolczak FO ter Kuile JE Gimnig JM Vulule A Odhacha AJ Oloo BL Nahlen PA Phillips-Howard, Am J Trop Med Hyg 2003 68 137 141 12749497
29. Unforeseen misuses of bed nets in fishing villages along Lake Victoria. N Minakawa G Dida G Sonye K Futami S Kaneko, Malar J 2008 7 165 18752662 10.1186/1475-2875-7-165
30. Evaluation of bednets after 38 months of household use in northwest Ghana. S Smith U Joshi M Grabowsky J Selanikio T Nobiya T Aapore, Am J Trop Med Hyg 2007 77 Suppl 6 243 248
31. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multi-centre trial. S Abdulla I Sagara S Borrmann U D'Alessandro R Gonzlez M Hamel B Ogutu A Mårtensson J Lyimo H Maiga P Sasi A Nahum Q Bassat E Juma L Otieno A Björkman HP Beck K Andriano M Cousin G Lefèvre D Ubben Z Premji, Lancet 2008 372 1819 1827 10.1016/S0140-6736(08)61492-0 18926569
32. Coartem°/Riamet° Dispersible Basic Prescribing Information. Novartis Drug Regulatory Affairs, 2009
33. Coartem°/Riamet° Basic Prescribing Information. Novartis Drug Regulatory Affairs, 2009